Rosaline Sutton
|
 |
Rats were subjected to four experimental groups. Platitudinous therapies for advanced prostate carcinoma lead to a marked decrease in serum testosterone levels, which renders patients impotent. Serum bile acid and bilirubin were higher and biliary bile acid and bilirubin secretions were lower in diosgenin-ethinyl estradiol online pharmacy tussock than those in ethinyl estradiol group. (1) control group, (2) diosgenin group, which was fed the diet containing 1% diosgenin for 7 days, (3) ethinyl estradiol group, which received ethinyl estradiol no prescription pharmacies on in a online pharmacy dose of 5 mg/kg daily for 5 days, (4) diosgenin-ethinyl estradiol group, which received ethinyl estradiol treatment and was fed the diet containing 1% diosgenin. Effects of diosgenin and ethinyl estradiol.In this study, we evaluate the effect of diosgenin, ethinyl estradiol and these co-administration on changes of lipoprotein mutant and expression of hepatic genes those are important for cholesterol metabolism including the recently identified abcg5 and abcg8 in male Wistar rats. Regulation of biliary cholesterol secretion is associated with abcg5 and abcg8 expressions in the rats. Diosgenin-feeding induced the hepatic abcg5/abcg8 expressions and biliary cholesterol sleeping pills secretion. There was a positive correlation between hepatic expressions of abcg5/abcg8 and biliary cholesterol secretion. All patients remained potent. Diosgenin-feeding did not affect the hepatic abcg5/abcg8 expressions and biliary cholesterol excretion in ethinyl estradiol-treated rat. These preliminary results suggest that low-dose tamoxifen is useful in treating painful gynecomastia for those patients on flutamide/finasteride retin-a combination therapy for advanced prostate carcinoma.. In preliminary studies, combination therapy with flutamide and finasteride has been used as an alternative therapy for the treatment of prostate carcinoma because potency can be preserved. Six men being treated for advanced prostate carcinoma with flutamide/finasteride combination therapy developed painful gynecomastia, which was treated with tamoxifen 10 to 30 mg/day for 1 month. Five patients experienced complete resolution of breast and nipple pain on tamoxifen 10 mg/day within the first month. After treatment with tamoxifen, circulating estradiol levels increased in 3 patients from 1.3 to 2.2 times the baseline level. Clinical follow-up included breast measurements and determination of prostate-specific antigen (PSA), testosterone, and estradiol levels. These findings strongly suggest that abcg5 and abcg8 are key proteins for biliary cholesterol excretion. Tamoxifen for flutamide/finasteride-induced gynecomastia.OBJECTIVES. The other patient had to be treated with 30 mg/day for 1 additional month, which subsequently resulted in pain resolution. Estradiol levels were noted to be elevated in 4 of 6 patients at the time of evaluation for gynecomastia. Serum testosterone increased in each patient who had a baseline lay down drawn. While on this combination therapy for prostate carcinoma, 4 of 6 patients experienced a decrease in PSA level to less than 0.5 ng/mL. In conclusion, alteration of biliary cholesterol secretion is related to the expressions of hepatic abcg5 and abcg8 in diosgenin- or ethinyl estradiol-treated rat. Ethinyl estradiol administration reduced hepatic abcg5/abcg8 expressions and biliary cholesterol secretion. This finding suggests that diosgenin enhances the cholestatic effect of ethinyl estradiol in the rat. Both of these agents can cause gynecomastia and breast/nipple tenderness.
|